Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins
Tumor targeting is a booming business: The global therapeutic monoclonal antibody market accounted for more than $78 billion in 2012 and is expanding exponentially. Tumors can be targeted with an extensive arsenal of monoclonal antibodies, ligand proteins, peptides, RNAs, and small molecules. In add...
Main Authors: | Boonstra, Martin C., de Geus, Susanna W.L., Prevoo, Hendrica A.J.M., Hawinkels, Lukas J.A.C., van de Velde, Cornelis J.H., Kuppen, Peter J.K., Vahrmeijer, Alexander L., Sier, Cornelis F.M. |
---|---|
Format: | Online |
Language: | English |
Published: |
Libertas Academica
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040425/ |
Similar Items
-
Expression of uPAR in tumor-associated stromal cells is associated with colorectal cancer patient prognosis: a TMA study
by: Boonstra, Martin C, et al.
Published: (2014) -
uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery
by: Boonstra, Martin C., et al.
Published: (2015) -
Stromal Targets for Fluorescent-Guided Oncologic Surgery
by: Boonstra, Martin C., et al.
Published: (2015) -
Cytoplasmic Overexpression of HER2: a Key Factor in Colorectal Cancer
by: Blok, Erik J, et al.
Published: (2013) -
Selecting Tumor-Specific Molecular Targets in Pancreatic Adenocarcinoma: Paving the Way for Image-Guided Pancreatic Surgery
by: de Geus, Susanna W. L., et al.
Published: (2016)